vs
ASP Isotopes Inc.（ASPI）与礼来（RNA）财务数据对比。点击上方公司名可切换其他公司
ASP Isotopes Inc.的季度营收约是礼来的1.3倍（$16.7M vs $12.5M），ASP Isotopes Inc.同比增速更快（1295.7% vs 434.0%），ASP Isotopes Inc.自由现金流更多（$-47.4M vs $-156.9M）
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
ASPI vs RNA — 直观对比
营收规模更大
ASPI
是对方的1.3倍
$12.5M
营收增速更快
ASPI
高出861.6%
434.0%
自由现金流更多
ASPI
多$109.5M
$-156.9M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.7M | $12.5M |
| 净利润 | — | $-174.4M |
| 毛利率 | 12.5% | — |
| 营业利润率 | — | -1513.5% |
| 净利率 | — | -1398.3% |
| 营收同比 | 1295.7% | 434.0% |
| 净利润同比 | -586.8% | -117.0% |
| 每股收益（稀释后） | — | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPIRNA
| Q4 25 | $16.7M | — | ||
| Q3 25 | $4.9M | $12.5M | ||
| Q2 25 | — | $3.8M | ||
| Q1 25 | — | $1.6M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $2.0M | ||
| Q1 24 | — | $3.5M |
净利润ASPIRNA
| Q4 25 | — | — | ||
| Q3 25 | $-12.9M | $-174.4M | ||
| Q2 25 | — | $-157.3M | ||
| Q1 25 | — | $-115.8M | ||
| Q4 24 | — | $-102.3M | ||
| Q3 24 | — | $-80.4M | ||
| Q2 24 | — | $-70.8M | ||
| Q1 24 | — | $-68.9M |
毛利率ASPIRNA
| Q4 25 | 12.5% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ASPIRNA
| Q4 25 | — | — | ||
| Q3 25 | -306.1% | -1513.5% | ||
| Q2 25 | — | -4448.7% | ||
| Q1 25 | — | -8360.9% | ||
| Q4 24 | — | -4069.6% | ||
| Q3 24 | — | -4200.9% | ||
| Q2 24 | — | -4040.4% | ||
| Q1 24 | — | -2178.6% |
净利率ASPIRNA
| Q4 25 | — | — | ||
| Q3 25 | -263.7% | -1398.3% | ||
| Q2 25 | — | -4089.3% | ||
| Q1 25 | — | -7360.0% | ||
| Q4 24 | — | -3439.5% | ||
| Q3 24 | — | -3441.7% | ||
| Q2 24 | — | -3461.8% | ||
| Q1 24 | — | -1943.4% |
每股收益（稀释后）ASPIRNA
| Q4 25 | — | — | ||
| Q3 25 | $-0.15 | $-1.27 | ||
| Q2 25 | — | $-1.21 | ||
| Q1 25 | — | $-0.90 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | — | $-0.65 | ||
| Q2 24 | — | $-0.65 | ||
| Q1 24 | — | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $350.2M |
| 总债务越低越好 | $14.4M | — |
| 股东权益账面价值 | $204.2M | $1.9B |
| 总资产 | $498.0M | $2.1B |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资ASPIRNA
| Q4 25 | $333.3M | — | ||
| Q3 25 | $113.9M | $350.2M | ||
| Q2 25 | — | $243.9M | ||
| Q1 25 | — | $254.2M | ||
| Q4 24 | — | $219.9M | ||
| Q3 24 | — | $370.2M | ||
| Q2 24 | — | $575.8M | ||
| Q1 24 | — | $471.4M |
总债务ASPIRNA
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ASPIRNA
| Q4 25 | $204.2M | — | ||
| Q3 25 | $74.1M | $1.9B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $830.9M |
总资产ASPIRNA
| Q4 25 | $498.0M | — | ||
| Q3 25 | $225.9M | $2.1B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $951.5M |
负债/权益比ASPIRNA
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | $-156.9M |
| 自由现金流率自由现金流/营收 | -284.7% | -1257.6% |
| 资本支出强度资本支出/营收 | 57.9% | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-592.3M |
8季度趋势，按日历期对齐
经营现金流ASPIRNA
| Q4 25 | $-37.8M | — | ||
| Q3 25 | $-8.9M | $-156.2M | ||
| Q2 25 | — | $-199.7M | ||
| Q1 25 | — | $-124.8M | ||
| Q4 24 | — | $-99.9M | ||
| Q3 24 | — | $-65.6M | ||
| Q2 24 | — | $-65.0M | ||
| Q1 24 | — | $-70.4M |
自由现金流ASPIRNA
| Q4 25 | $-47.4M | — | ||
| Q3 25 | $-12.0M | $-156.9M | ||
| Q2 25 | — | $-203.0M | ||
| Q1 25 | — | $-128.6M | ||
| Q4 24 | — | $-103.8M | ||
| Q3 24 | — | $-67.3M | ||
| Q2 24 | — | $-65.5M | ||
| Q1 24 | — | $-71.3M |
自由现金流率ASPIRNA
| Q4 25 | -284.7% | — | ||
| Q3 25 | -245.5% | -1257.6% | ||
| Q2 25 | — | -5277.1% | ||
| Q1 25 | — | -8174.3% | ||
| Q4 24 | — | -3491.0% | ||
| Q3 24 | — | -2881.8% | ||
| Q2 24 | — | -3204.6% | ||
| Q1 24 | — | -2012.3% |
资本支出强度ASPIRNA
| Q4 25 | 57.9% | — | ||
| Q3 25 | 64.4% | 5.7% | ||
| Q2 25 | — | 86.9% | ||
| Q1 25 | — | 238.6% | ||
| Q4 24 | — | 131.7% | ||
| Q3 24 | — | 72.9% | ||
| Q2 24 | — | 26.0% | ||
| Q1 24 | — | 25.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
